Yu L, Wang C, Pan F, Liu Y, Ren X, Zeng H, et al. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling. Biomed Pharmacother. 2019;118:109361 pubmed publisher

Kim J, Lee J, Hwang H, Lee D, Park C, Jung S, et al. Wnt signal activation induces midbrain specification through direct binding of the beta-catenin/TCF4 complex to the EN1 promoter in human pluripotent stem cells. Exp Mol Med. 2018;50:24 pubmed publisher

Wang W, Xiao X, Chen X, Huo Y, Xi W, Lin Z, et al. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer. Int J Cancer. 2018;142:308-321 pubmed publisher

Yukimori A, Oikawa Y, Morita K, Nguyen C, Harada H, Yamaguchi S, et al. Genetic basis of calcifying cystic odontogenic tumors. PLoS ONE. 2017;12:e0180224 pubmed publisher

Qu Y, Gharbi N, Yuan X, Olsen J, Blicher P, Dalhus B, et al. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proc Natl Acad Sci U S A. 2016;113:9339-44 pubmed publisher

Park C, Kim H, Jang J, Lee H, Lee J, Yoo J, et al. ABCD2 is a direct target of ?-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy. PLoS ONE. 2013;8:e56242 pubmed publisher